ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells

Published:2016-03 Issue:3 Volume:48 Page:e222-e222
ISSN:2092-6413
Container-title:Experimental & Molecular Medicine
language:en
Short-container-title:Exp Mol Med

Author:

Baik Seung Hyun,Lee Jongkuen,Lee Yeong-Shin,Jang Ji-Young,Kim Chul-Woo

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://www.nature.com/articles/emm2015126.pdf

Reference34 articles.

1. Sassen S, Miska EA, Caldas C . MicroRNA: implications for cancer. Virchows Arch 2008; 452: 1–10.

2. Garzon R, Calin GA, Croce CM . MicroRNAs in cancer. Annu Rev Med 2009; 60: 167–179.

3. Slack FJ, Weidhaas JB . MicroRNA in cancer prognosis. N Engl J Med 2008; 359: 2720–2722.

4. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834–838.

5. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257–2261.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway;Frontiers in Cell and Developmental Biology;2024-08-02

2. Exploring the multifaceted role of adenosine nucleotide translocase 2 in cellular and disease processes: A comprehensive review;Life Sciences;2024-08

3. Disrupting CCDC137-mediated LZTS2 and β-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via β-catenin and AKT;Cell Death & Differentiation;2024-06-25

4. CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology;Journal of Translational Medicine;2024-01-12

5. Decoding the interaction between miR-19a and CBX7 focusing on the implications for tumor suppression in cancer therapy;Medical Oncology;2023-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3